Financings Of The Fortnight: Radius Finds An Alternate Route For Going Public
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financings by BioCritica, GenKyoTex, SpringLeaf Therapeutics and ImmunoGen.